These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 24628949)

  • 1. FOXM1 mediates resistance to docetaxel in gastric cancer via up-regulating Stathmin.
    Li X; Yao R; Yue L; Qiu W; Qi W; Liu S; Yao Y; Liang J
    J Cell Mol Med; 2014 May; 18(5):811-23. PubMed ID: 24628949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forkhead box transcription factor 1 expression in gastric cancer: FOXM1 is a poor prognostic factor and mediates resistance to docetaxel.
    Li X; Qiu W; Liu B; Yao R; Liu S; Yao Y; Liang J
    J Transl Med; 2013 Sep; 11():204. PubMed ID: 24004449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer.
    Okada K; Fujiwara Y; Takahashi T; Nakamura Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
    Ann Surg Oncol; 2013 Mar; 20(3):1035-43. PubMed ID: 23054116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of Chemosensitivity by Stathmin-1 Silencing in Gastric Cancer Cells In Situ and In Vivo.
    Meng ZJ; Tao K
    Oncol Res; 2016 Jan; 23(1-2):35-41. PubMed ID: 26802649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The FOXM1-induced resistance to oxaliplatin is partially mediated by its novel target gene Mcl-1 in gastric cancer cells.
    Hu CJ; Wang B; Tang B; Chen BJ; Xiao YF; Qin Y; Yong X; Luo G; Zhang JW; Zhang D; Li S; He F; Yang SM
    Biochim Biophys Acta; 2015 Mar; 1849(3):290-9. PubMed ID: 25482013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FoxM1 expression is significantly associated with cisplatin-based chemotherapy resistance and poor prognosis in advanced non-small cell lung cancer patients.
    Wang Y; Wen L; Zhao SH; Ai ZH; Guo JZ; Liu WC
    Lung Cancer; 2013 Feb; 79(2):173-9. PubMed ID: 23177020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of the FoxM1 enhances the sensitivity of gastric cancer cells to cisplatin by targeting Mcl-1.
    Li X; Liang J; Liu YX; Wang Y; Yang XH; Bao-Hongluan ; Zhang GL; Du J; Wu XH
    Pharmazie; 2016 Jun; 71(6):345-8. PubMed ID: 27455555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FoxM1 is up-regulated in gastric cancer and its inhibition leads to cellular senescence, partially dependent on p27 kip1.
    Zeng J; Wang L; Li Q; Li W; Björkholm M; Jia J; Xu D
    J Pathol; 2009 Aug; 218(4):419-27. PubMed ID: 19235838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiostrepton confers protection against reactive oxygen species-related apoptosis by restraining FOXM1-triggerred development of gastric cancer.
    Liu SX; Zhou Y; Zhao L; Zhou LS; Sun J; Liu GJ; Du YS; Zhou YN
    Free Radic Biol Med; 2022 Nov; 193(Pt 1):385-404. PubMed ID: 36152915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression.
    Kwok JM; Myatt SS; Marson CM; Coombes RC; Constantinidou D; Lam EW
    Mol Cancer Ther; 2008 Jul; 7(7):2022-32. PubMed ID: 18645012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FoxM1 mediates resistance to herceptin and paclitaxel.
    Carr JR; Park HJ; Wang Z; Kiefer MM; Raychaudhuri P
    Cancer Res; 2010 Jun; 70(12):5054-63. PubMed ID: 20530690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-FLIP promotes drug resistance in non-small-cell lung cancer cells via upregulating FoxM1 expression.
    Wang WD; Shang Y; Wang C; Ni J; Wang AM; Li GJ; Su L; Chen SZ
    Acta Pharmacol Sin; 2022 Nov; 43(11):2956-2966. PubMed ID: 35422085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXM1 confers acquired cisplatin resistance in breast cancer cells.
    Kwok JM; Peck B; Monteiro LJ; Schwenen HD; Millour J; Coombes RC; Myatt SS; Lam EW
    Mol Cancer Res; 2010 Jan; 8(1):24-34. PubMed ID: 20068070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of FoxM1 by thiostrepton or small interfering RNA inhibits proliferation, transformation ability and angiogenesis, and induces apoptosis of nasopharyngeal carcinoma cells.
    Jiang L; Wang P; Chen L; Chen H
    Int J Clin Exp Pathol; 2014; 7(9):5450-60. PubMed ID: 25337187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanism of Forkhead box M1 inhibition by thiostrepton in breast cancer cells.
    Kongsema M; Wongkhieo S; Khongkow M; Lam EW; Boonnoy P; Vongsangnak W; Wong-Ekkabut J
    Oncol Rep; 2019 Sep; 42(3):953-962. PubMed ID: 31322278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of an AKT/FOXM1/STMN1 pathway drives resistance to tyrosine kinase inhibitors in lung cancer.
    Li M; Yang J; Zhou W; Ren Y; Wang X; Chen H; Zhang J; Chen J; Sun Y; Cui L; Liu X; Wang L; Wu C
    Br J Cancer; 2017 Sep; 117(7):974-983. PubMed ID: 28850563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrantly high activation of a FoxM1-STMN1 axis contributes to progression and tumorigenesis in FoxM1-driven cancers.
    Liu J; Li J; Wang K; Liu H; Sun J; Zhao X; Yu Y; Qiao Y; Wu Y; Zhang X; Zhang R; Yang A
    Signal Transduct Target Ther; 2021 Feb; 6(1):42. PubMed ID: 33526768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FoxM1 inhibition enhances chemosensitivity of docetaxel-resistant A549 cells to docetaxel via activation of JNK/mitochondrial pathway.
    Wang K; Zhu X; Zhang K; Zhu L; Zhou F
    Acta Biochim Biophys Sin (Shanghai); 2016 Sep; 48(9):804-9. PubMed ID: 27521795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twist1 promotes gastric cancer cell proliferation through up-regulation of FoxM1.
    Qian J; Luo Y; Gu X; Zhan W; Wang X
    PLoS One; 2013; 8(10):e77625. PubMed ID: 24204899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Forkhead box M1 in soft tissue leiomyosarcoma: Clinicopathologic and in vitro study using a newly established cell line.
    Maekawa A; Kohashi K; Setsu N; Kuda M; Iura K; Ishii T; Matsunobu T; Nakatsura T; Iwamoto Y; Oda Y
    Cancer Sci; 2016 Jan; 107(1):95-102. PubMed ID: 26560505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.